Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Use to optimize drug therapy and monitor patient adherence.
MnemonicUnique test identifier.
CHLORP SP
MethodologyProcess(es) used to perform the test.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
PerformedDays of the week the test is performed.
Mon
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
Within 8 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Timing of specimen collection: Predose (trough) draw - At steady state concentration.
Collect
Plain red. Also acceptable: Lavender (K2 or K3EDTA), pink (K2EDTA), green (Heparin) or gray (Potassium oxalate or Sodium fluoride).
Specimen Preparation
Separate serum or plasma from cells within 2 hours of collection. Transfer 2 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Whole blood. Hemolyzed specimens. Gel separator tubes, light blue (citrate) or yellow (SPS or ACD solution).
Remarks
Stability
After separation from cells: Ambient: Unacceptable; Refrigerated: 14 days; Frozen: 14 days
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Therapeutic Range
30-300 ng/mL
Toxic Level
Greater than or equal to 600 ng/mL
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Chlorpromazine is a neuroleptic drug indicated for the treatment of schizophrenia, psychotic disorders and intractable hiccup. Chlorpromazine should not be used in patients who have epilepsy, Parkinson's disease, hypoparathyroidism, myasthenia gravis, and prostatic hypertrophy. Adverse effects may include drowsiness, hypotension, agranulocytosis, cardiac abnormalities, seizures and rare life-threatening effects, such as phenothiazine sudden death syndrome, and neuroleptic malignant syndrome.
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
Chat
Feedback
